Aripiprazole Orally Disintegrating Tablets and Canakinumab Subcutaneous
Determining the interaction of Aripiprazole Orally Disintegrating Tablets and Canakinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aripiprazole
Brand name: Abilify, Abilify Discmelt, Abilify Maintena, Aristada, Abilify MyCite, Aristada Initio
Synonyms: Aripiprazole, ARIPiprazole
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aripiprazole Orally Disintegrating Tablets-Canasa
- Aripiprazole Orally Disintegrating Tablets-Canasa Pac rectal
- Aripiprazole Orally Disintegrating Tablets-Canasa rectal
- Aripiprazole Orally Disintegrating Tablets-Cancidas
- Aripiprazole Orally Disintegrating Tablets-Candesartan
- Aripiprazole Orally Disintegrating Tablets-Candesartan and Hydrochlorothiazide
- Canakinumab Subcutaneous-Aripiprazole Tablets
- Canakinumab Subcutaneous-Aripiprazole Tablets with Sensor
- Canakinumab Subcutaneous-Aripiprazole, ARIPiprazole Lauroxil
- Canakinumab Subcutaneous-Aristada
- Canakinumab Subcutaneous-Aristada Initio
- Canakinumab Subcutaneous-Aristada injection